Validify

Not every system change requires re‑validation under CSA ✅ The real question is not how big the change is. It is whether validated functionality is impacted. ✅ Often no re‑validation needed: ·        Configuration within validated parameters ·        Vendor patches with documented impact assessment ·        Infrastructure upgrades with regression evidence ⚠️ Almost always requires re‑validation: ·        Changes to validated workflows or data flows ·        New integrations with regulated systems CSA does not reduce control. It helps teams focus validation where risk actually exists. 👉 Read more: https://lnkd.in/etJBZzaH Which change type causes the most debate for your team? #CSA #ComputerSystemValidation #RiskBasedApproach #GxPCompliance #LifeSciences

Most FDA software validation findings are not about missing tests ❌ They are about missing reasoning. Auditors ask one simple question: how did you decide what to test? If risk assessment is disconnected from test coverage, there is no good answer. ✅What works: • Risk defined before testing • Test effort aligned to risk • Supplier evidence used to avoid duplicate testing FDA’s CSA guidance (Feb 2026) reinforces this shift: not more docs, but traceable thinking 🔍 If you can show risk → decision → test → evidence, you are on solid ground. 👉 Read more: https://lnkd.in/eJixvQXm What is hardest for you to keep traceable in practice? #CSA #ComputerSystemValidation #FDA #GxPCompliance #LifeSciences

📄 Most validation documentation is written to survive an audit, not to reflect how the system was actually evaluated. The result: Packages that are long, defensible on paper, and disconnected from any real risk thinking. FDA's CSA guidance shifts the standard. The question auditors are increasingly asking isn't "how much did you document?" - it's "how did you decide what to test?" Three things that answer that question: ✅ A risk assessment that was written before the test scripts, not after ✅ Test coverage that visibly maps to risk level - not uniform across all functions ✅ Supplier controls and existing quality evidence used to reduce redundant testing If your package can't show that chain of thinking, more documentation won't fix it. FDA CSA Guidance (Finalized Feb 2026): https://lnkd.in/ge9TumpF #FDA #ComputerSystemValidation #CSA #GxPCompliance #LifeSciences

CSA in practice - what clinical teams actually do differently Most teams hear "Computer System Assurance" and think it means less work. It doesn't. It means smarter work. The teams getting it right are doing three things: ✔️ Continuous risk visibility - not a snapshot at go-live ✔️ Testing focused where change actually happened ✔️ Documentation that stays current, not just complete That's exactly what we built our managed services around. If your team is managing EDC, RTSM, eConsent or eCOA - and you're tired of restarting validation every release cycle - this is worth 2 minutes of your time. ▶️ See how it works: https://lnkd.in/ew4ys28b #CSA #ClinicalOperations #RiskBasedApproach #GxPCompliance

CSA doesn’t stop at assessment. It only works when risk visibility continues after go-live. This short video shows how clinical teams use CSA principles to: ✔️ Stay ahead of system changes ✔️ Focus testing where it matters ✔️ Be audit-ready, without constant re-validation ▶️ Watch here: https://lnkd.in/e2ZP_E-C #CSA #ClinicalOperations #RiskBasedApproach #GxPCompliance

🚀 New at Validify: On‑going Risk Assessment & Validation Services Validation shouldn’t restart every time your system changes. We’ve launched On‑going Risk Assessment & Validation Services to help teams stay continuously compliant. Whether it’s EDC, eConsent, RTSM, eCOA, or other cloud‑based platforms, we keep risk assessments and validation up to date as releases roll out. No more one‑off projects ➡️ Choose always‑on assurance and audit‑ready documentation instead. Curious how it works? 👉 https://lnkd.in/ew4ys28b hashtag #ClinicalOperations #ComputerSystemAssurance #RiskBasedValidation

In our last article, we talked about how FDA expectations are shifting alongside automation and cloud platforms. But that shift creates a new challenge: How do you validate systems that change every week? Our newest post answers that question with a clear, practical exploration of risk‑based validation — a smarter way to stay compliant while keeping pace with continuous delivery. If your teams feel the strain of constant updates, this guidance is for you. 🔗 Read the new article on the Validify blog - https://lnkd.in/eQ9kbasM

🚀 New on the Validify Blog  The FDA’s expectations for computer system validation are evolving fast—and cloud platforms, automation, and CSA are reshaping how regulated organizations stay compliant.  Our latest post breaks down a practical framework for validation in modern, cloud‑driven environments.  If you’re navigating SaaS, automation, or continuous updates, this guide is for you.  👉 Read the full article: A Practical Guide to FDA Computer System Validation in the Era of Automation and Cloud Platforms https://lnkd.in/e8Gk7VAz

EDC system validation often becomes urgent when a timeline slips, a SaaS update hits, or an inspection question comes in. In this new blog, Ido Raz shares: >the biggest validation pitfalls sponsors run into >when outsourcing makes sense (and what to look for) >practical steps to stay inspection-ready without slowing trials 👉 Read the blog: https://bit.ly/46xsPvJ #ClinicalTrials #EDC #CSV #Quality #DataManagement

🔖 A must-read for QA and IT leaders navigating this landscape in the life-science industry.